PON2: A Promising Biomarker and Cancer Therapy Target
PON2, a member of the paraoxonase family of enzymes, has been primarily noted for its antioxidant properties. However, its implications ...
Tag: Precision Medicine in Oncology
Deep Radiomics Boost Chemotherapy Prediction in Breast Cancer
In an era where precision medicine is rapidly transforming cancer treatment paradigms, innovative approaches that harness the power of advanced ...
Essential Cancer Prevention Tips from Sylvester – June 2025 Edition
In a comprehensive update from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, remarkable ...
New Genetic Method Expands Access to Hereditary Breast and Ovarian Cancer Risk Testing for Women
A Breakthrough in Genetic Screening Offers New Hope for Families with Hereditary Cancer Risks For decades, the shadow of hereditary ...
